Author:
Feyssaguet Muriel,Bellanger Aurélie,Nozay Florence,Friel Damien,Merck Estelle,Verlant Vincent,Malevé Michel,Lallemand Stéphane,El Moussaoui Abdelkarim,De Gorguette D'Argoeuves Polly,Jones Tessa,Goldblatt David,Schoonbroodt Sonia
Funder
GlaxoSmithKline Biologicals SA
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference33 articles.
1. Pneumococcal capsules and their types: past, present, and future;Geno;Clin Microbiol Rev,2015
2. Cohen O, Knoll M, O’Brien K, Ramakrishnan M, Constenla D, Privor-Dumm L, et al. Pneumococcal Conjugate Vaccine (PCV) Product Assessment; 2017. [accessed 16 August 2018].
3. Pneumococcal vaccines WHO position paper - 2012;World Health Organization;Wkly Epidemiol Rec,2012
4. safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr Infect Dis J,2000
5. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia;Black;Pediatr Infect Dis J,2002